Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization

Abstract

This MR investigation provides evidence supporting the causal relationship between immune cell and pancreatic cancer, with plasma metabolites serving as mediators. Identifying immune cell phenotypes with potential causal effects on pancreatic cancer sheds light on its underlying mechanisms and suggests novel therapeutic targets.